{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:49:53Z","timestamp":1791319793262,"version":"4.3.1"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:00:00Z","timestamp":1720483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jconrel.2024.07.017","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T21:41:45Z","timestamp":1720993305000},"page":"70-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation"],"prefix":"10.1016","volume":"373","author":[{"given":"M. Teresa","family":"Perell\u00f3-Trias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jose","family":"Serrano-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Segura-Sampedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Maria","family":"Ramis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Monjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.07.017_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120041","article-title":"Drug delivery systems to prevent peritoneal metastasis after surgery of digestives or ovarian carcinoma: a review","volume":"592","author":"Roy","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","article-title":"Primary and metastatic peritoneal surface malignancies","volume":"7","author":"Cort\u00e9s-Guiral","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010103","article-title":"Development of the peritoneal metastasis: a review of Back-grounds, mechanisms, treatments and prospects","volume":"12","author":"Ren","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0020","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/17425247.2020.1736551","article-title":"Intraperitoneal chemotherapy for peritoneal metastases\u00a0: an expert opinion","volume":"17","author":"Ceelen","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0030","series-title":"Cytoreductive Surgery & Perioperative Chemotherapy for Peritoneal Surface Malignancy: Textbook and Video Atlas, Second Edition, Canada","author":"Bakrin","year":"2017"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0035","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","author":"Flessner","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PPO.0b013e3181a58d95","article-title":"Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy","volume":"15","author":"Van der Speeten","year":"2009","journal-title":"Cancer J."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/pp-2017-0004","article-title":"Modelling drug transport during intraperitoneal chemotherapy","volume":"2","author":"Steuperaert","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0050","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","article-title":"Peritoneal carcinomatosis","volume":"19","author":"Coccolini","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0055","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2021.101676","article-title":"The many faces of intraperitoneal chemotherapy","volume":"40","author":"Abdel Mageed","year":"2022","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: the surgeon\u2019s role","volume":"384","author":"Sugarbaker","year":"1999","journal-title":"Langenbeck\u2019s Arch. Surg."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0070","series-title":"Exploring Drug Delivery to the Peritoneum","year":"2023"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0075","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11864-023-01171-3","article-title":"Intraperitoneal and Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian Cancer","volume":"25","author":"Wang","year":"2024","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cncr.23553","article-title":"Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer","volume":"113","author":"Di Giorgio","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian Cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0095","first-page":"236","article-title":"Anaesthetic considerations in the perioperative Management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy., Indian","volume":"7","author":"Sheshadri","year":"2016","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520983263","article-title":"Physiologic and hemodynamic changes in patients undergoing open abdominal cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"49","author":"Kim","year":"2021","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1245\/s10434-019-07495-5","article-title":"Elevated maximum Core body temperature during Hyperthermic intraperitoneal Chemoperfusion (HIPEC) is associated with increased postoperative complications","volume":"27","author":"Hendrix","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","article-title":"Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization","volume":"74","author":"Fukumura","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0169-409X(00)00131-9","article-title":"Delivery of molecular and cellular medicine to solid tumors","volume":"46","author":"Jain","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11095-009-0031-z","article-title":"Drug delivery systems for intraperitoneal therapy","volume":"27","author":"Bajaj","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0125","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2023.03.004","article-title":"Biomaterial-based platforms for modulating immune components against cancer and cancer stem cells","volume":"161","author":"Desai","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/720858","article-title":"Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent","volume":"2013","author":"De Smet","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0140","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/10717544.2018.1466937","article-title":"Drug delivery systems based on biocompatible imino-chitosan hydrogels for local anticancer therapy","volume":"25","author":"Ailincai","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00595-013-0674-6","article-title":"Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer","volume":"44","author":"Emoto","year":"2014","journal-title":"Surg. Today"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2016.05.056","article-title":"Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals","volume":"235","author":"Sun","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/marc.201800007","article-title":"Cholesterol modification of an anticancer drug for efficient incorporation into a supramolecular hydrogel system","volume":"39","author":"Bakker","year":"2018","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.202300005","article-title":"Development of a supramolecular hydrogel for intraperitoneal injections","volume":"24","author":"Wintjens","year":"2024","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0165","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1039\/C8BM01442F","article-title":"Enhanced local cancer therapy using a CA4P and CDDP co-loaded polypeptide gel depot","volume":"7","author":"Yu","year":"2019","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/1471-2407-10-402","article-title":"5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice","volume":"10","author":"Wang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0175","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2017.10.022","article-title":"Pre-clinical evaluation of a themosensitive gel containing epothilone B and mTOR\/Hsp90 targeted agents in an ovarian tumor model","volume":"268","author":"Shin","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0180","first-page":"1","article-title":"Sustained co-delivery of 5-fluorouracil and cis-platinum via biodegradable thermo-sensitive hydrogel for intraoperative synergistic combination chemotherapy of gastric cancer","volume":"23","author":"Chen","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0185","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/10717544.2018.1440444","article-title":"Novel application of pluronic lecithin organogels (PLOs) for local delivery of synergistic combination of docetaxel and cisplatin to improve therapeutic efficacy against ovarian cancer","volume":"25","author":"Chang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0190","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejpb.2020.10.011","article-title":"Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer","volume":"157","author":"Al Sabbagh","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/polym12030580","article-title":"Poly(N-isopropylacrylamide)-based Thermoresponsive composite hydrogels for biomedical applications","volume":"12","author":"Xu","year":"2020","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112483","article-title":"Development of \u201con-demand\u201d thermo-responsive hydrogels for anti-cancer drugs sustained release: rational design, in silico prediction and in vitro validation in colon cancer models","volume":"131","author":"Carre\u00f1o","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0205","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3390\/ijms19051373","article-title":"Thermosensitive injectable hydrogel for simultaneous intraperitoneal delivery of doxorubicin and prevention of peritoneal adhesion","volume":"19","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0210","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/acs.molpharmaceut.8b00836","article-title":"3D printing of Poloxamer 407 Nanogel discs and their applications in adjuvant ovarian Cancer therapy","volume":"16","author":"Cho","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.20892\/j.issn.2095-3941.2019.0169","article-title":"The role of a drug-loaded poly (lactic co-glycolic acid) (PLGA) copolymer stent in the treatment of ovarian cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0220","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0225","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2018.07.045","article-title":"Effective sustained release of 5-FU-loaded PLGA implant for improving therapeutic index of 5-FU in colon tumor","volume":"550","author":"Li","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0230","doi-asserted-by":"crossref","first-page":"1175617","DOI":"10.3389\/fonc.2023.1175617","article-title":"Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0235","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12935-023-02854-5","article-title":"Tumor microenvironment in ovarian cancer peritoneal metastasis","volume":"23","author":"Mei","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","article-title":"The acidic tumor microenvironment as a driver of Cancer","volume":"82","author":"Boedtkjer","year":"2020","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ma15051934","article-title":"Electrospun nanofibers revisited: an update on the emerging applications in nanomedicine","volume":"15","author":"Elsadek","year":"2022","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0250","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00280-007-0449-0","article-title":"Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model","volume":"60","author":"Vassileva","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2012.05.047","article-title":"3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells","volume":"162","author":"Yohe","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0260","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3109\/10717544.2014.916768","article-title":"Antitumor activity of electrospun polylactide nanofibers loaded with 5-fluorouracil and oxaliplatin against colorectal cancer","volume":"23","author":"Zhang","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0265","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11095-020-02818-8","article-title":"Tuning the physicochemical characteristics of particle-based carriers for intraperitoneal local chemotherapy","volume":"37","author":"Alavi","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0270","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0275","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/pharmaceutics11080395","article-title":"Oxaliplatin-biomimetic magnetic nanoparticle assemblies for Colon Cancer-targeted chemotherapy: an in vitro study","volume":"11","author":"Jabalera","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0280","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1021\/acsnano.0c10276","article-title":"Tumor-selective immune-active mild hyperthermia associated with chemotherapy in Colon peritoneal metastasis by Photoactivation of fluorouracil-gold nanoparticle complexes","volume":"15","author":"Mulens-Arias","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25246049","article-title":"Methotrexate gold Nanocarriers: loading and release study: its activity in Colon and Lung Cancer cells","volume":"25","author":"\u00c1lvarez-Gonz\u00e1lez","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0290","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/21691401.2017.1296850","article-title":"Microniosomes for concurrent doxorubicin and iron oxide nanoparticles loading; preparation, characterization and cytotoxicity studies","volume":"46","author":"Behnam","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms232012287","article-title":"Magneto-fluorescent mesoporous Nanocarriers for the dual-delivery of Ofloxacin and doxorubicin to tackle opportunistic bacterial infections in colorectal Cancer","volume":"23","author":"Marcelo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0300","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.biomaterials.2018.07.028","article-title":"Magnetic field-inducible drug-eluting nanoparticles for image-guided thermo-chemotherapy","volume":"180","author":"Thirunavukkarasu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0305","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.surg.2013.04.054","article-title":"A novel drug delivery system of intraperitoneal chemotherapy for peritoneal carcinomatosis using gelatin microspheres incorporating cisplatin","volume":"154","author":"Gunji","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121534","article-title":"Ultra-high drug loading improves nanoparticle efficacy against peritoneal mesothelioma","volume":"285","author":"Sabatelle","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0315","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1245\/s10434-012-2696-5","article-title":"Cytoreductive surgery and intraoperative administration of paclitaxel-loaded expansile nanoparticles delay tumor recurrence in ovarian carcinoma","volume":"20","author":"Gilmore","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0320","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/1535-7163.MCT-15-0713-T","article-title":"Paclitaxel-loaded Polymersomes for enhanced intraperitoneal chemotherapy","volume":"15","author":"Sim\u00f3n-Gracia","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0325","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.biomaterials.2010.09.059","article-title":"The performance of expansile nanoparticles in a murine model of peritoneal carcinomatosis","volume":"32","author":"Colson","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/jfb10040055","article-title":"Double-emulsion Copolyester microcapsules for sustained intraperitoneal release of carboplatin","volume":"10","author":"Cymbaluk-P\u0142oska","year":"2019","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0335","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s11095-007-9298-0","article-title":"Effects of carrier on disposition and antitumor activity of intraperitoneal paclitaxel","volume":"24","author":"Tsai","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0340","article-title":"Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models","volume":"48","author":"Hyldbakk","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.108.140095","article-title":"Tumor-penetrating microparticles for intraperitoneal therapy of ovarian cancer","volume":"327","author":"Lu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2022.12.012","article-title":"Thiolated pectin-chitosan composites: potential mucoadhesive drug delivery system with selective cytotoxicity towards colorectal cancer","volume":"225","author":"Leonard","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0355","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.colsurfb.2015.02.042","article-title":"Surface charge effect on mucoadhesion of chitosan based nanogels for local anti-colorectal cancer drug delivery","volume":"128","author":"Feng","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121189","article-title":"The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis","volume":"279","author":"Kim","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0365","doi-asserted-by":"crossref","first-page":"8548","DOI":"10.1016\/j.biomaterials.2011.07.067","article-title":"Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis","volume":"32","author":"Werner","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0370","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.biomaterials.2018.03.051","article-title":"Programmed \u201ctriple-mode\u201d anti-tumor therapy: improving peritoneal retention, tumor penetration and activatable drug release properties for effective inhibition of peritoneal carcinomatosis","volume":"169","author":"Cherukula","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0375","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.2147\/IJN.S247114","article-title":"Nanotechnology-based cisplatin intracellular delivery to enhance chemo-sensitivity of ovarian Cancer","volume":"15","author":"Bortot","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0380","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1021\/bm5011933","article-title":"Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model","volume":"15","author":"Amoozgar","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0385","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00595-019-01792-y","article-title":"Intraperitoneal chemotherapy for peritoneal metastases using sustained release formula of cisplatin-incorporated gelatin hydrogel granules","volume":"49","author":"Yamashita","year":"2019","journal-title":"Surg. Today"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0390","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1349-7006.1996.tb00238.x","article-title":"Improvement of intraperitoneal chemotherapy for rat ovarian cancer using cisplatin-containing microspheres","volume":"87","author":"Kumagai","year":"1996","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0395","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1166\/jnn.2016.11918","article-title":"Poly(lactic-co-glycolic) acid\/Solutol HS15-based nanoparticles for docetaxel delivery","volume":"16","author":"Cho","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0400","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.2174\/1871520622666220418141640","article-title":"Liposomal drug delivery and its potential impact on Cancer research","volume":"22","author":"Bhattacharya","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0405","first-page":"33","article-title":"Feasibility of tailored, selective and effective anticancer chemotherapy by direct injection of docetaxel-loaded immunoliposomes into Her2\/neu positive gastric tumor xenografts","volume":"38","author":"Yamamoto","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12080736","article-title":"Preparation and evaluation of intraperitoneal Long-acting Oxaliplatin-loaded multi-vesicular liposomal depot for colorectal Cancer treatment","volume":"12","author":"Abuzar","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031498","article-title":"A review of different types of liposomes and their advancements as a form of gene therapy treatment for breast Cancer","volume":"28","author":"Tseu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0420","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nano.2010.05.003","article-title":"Reduced dose-limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes","volume":"6","author":"Chang","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0425","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.lfs.2009.02.002","article-title":"Acute toxicity of long-circulating and pH-sensitive liposomes containing cisplatin in mice after intraperitoneal administration","volume":"84","author":"Leite","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0430","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/21691401.2019.1576705","article-title":"Sustained release paclitaxel-loaded core-shell-structured solid lipid microparticles for intraperitoneal chemotherapy of ovarian cancer","volume":"47","author":"Han","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0435","article-title":"mPEG-PDLLA micelles potentiate docetaxel for intraperitoneal chemotherapy in ovarian Cancer peritoneal metastasis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0440","first-page":"7291","article-title":"Enhanced antitumor effects by docetaxel\/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer","volume":"10","author":"Fan","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0445","article-title":"In situ gelatinase-responsive and thermosensitive nanocomplex for local therapy of gastric cancer with peritoneal metastasis","volume":"15","author":"Wang","year":"2022","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121828","article-title":"Development of a nanocapsule-loaded hydrogel for drug delivery for intraperitoneal administration","volume":"622","author":"Teja Surikutchi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0455","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijbiomac.2020.02.326","article-title":"Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis","volume":"152","author":"Luo","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0460","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejpb.2016.05.010","article-title":"Thermosensitive hydrogel system assembled by PTX-loaded copolymer nanoparticles for sustained intraperitoneal chemotherapy of peritoneal carcinomatosis","volume":"104","author":"Xu","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0465","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1021\/acsbiomaterials.8b01557","article-title":"Therapy for gastric Cancer with peritoneal metastasis using injectable albumin hydrogel hybridized with paclitaxel-loaded red blood cell membrane nanoparticles","volume":"5","author":"Qian","year":"2019","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0470","doi-asserted-by":"crossref","first-page":"26546","DOI":"10.1038\/srep26546","article-title":"Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0475","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2217\/nnm.14.211","article-title":"Novel injectable thermosensitive hydrogels for delivering hyaluronic acid-doxorubicin nanocomplexes to locally treat tumors","volume":"10","author":"Jhan","year":"2015","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0480","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jps.22256","article-title":"A novel composite hydrogel based on chitosan and inorganic phosphate for local drug delivery of camptothecin nanocolloids","volume":"100","author":"Li","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mabi.201600262","article-title":"Use of 5-fluorouracil loaded micelles and cisplatin in thermosensitive chitosan hydrogel as an efficient therapy against colorectal peritoneal Carcinomatosis","volume":"17","author":"Yun","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119859","article-title":"Smart and eco-friendly N-isopropylacrylamide and cellulose hydrogels as a safe dual-drug local cancer therapy approach","volume":"295","author":"Andrade","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0495","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2009.01.007","article-title":"A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel","volume":"135","author":"Yang","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0500","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1021\/acs.molpharmaceut.1c00514","article-title":"Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a hybrid system containing an Alginic acid-based Nanogel and an in situ cross-linkable hydrogel for peritoneal dissemination of ovarian Cancer","volume":"18","author":"Yamaguchi","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0505","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biomaterials.2014.10.039","article-title":"Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer","volume":"37","author":"Cho","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0510","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1016\/j.apsb.2023.04.006","article-title":"Orange-derived extracellular vesicles nanodrugs for efficient treatment of ovarian cancer assisted by transcytosis effect","volume":"13","author":"Long","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.117332","article-title":"Development of mucoadhesive hydrogels based on polyacrylic acid grafted cellulose nanocrystals for local cisplatin delivery","volume":"255","author":"Vakili","year":"2021","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0520","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2011.11.025","article-title":"An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels","volume":"158","author":"Zahedi","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0525","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ygyno.2011.05.032","article-title":"Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: experimental study in a murine model of ovarian cancer","volume":"122","author":"Colombo","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0530","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.022","article-title":"Enhanced anti-tumor efficacy and safety with metronomic intraperitoneal chemotherapy for metastatic ovarian cancer using biodegradable nanotextile implants","volume":"305","author":"Padmakumar","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0535","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.2147\/IJN.S186881","article-title":"Intraperitoneal delivery of NanoOlaparib for disseminated late-stage cancer treatment","volume":"13","author":"Baldwin","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0540","doi-asserted-by":"crossref","first-page":"14881","DOI":"10.1038\/s41598-019-51419-y","article-title":"Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer","volume":"9","author":"De Clercq","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0545","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10585-023-10210-0","article-title":"Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model","volume":"40","author":"Wintjens","year":"2023","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0550","doi-asserted-by":"crossref","first-page":"28373","DOI":"10.1038\/srep28373","article-title":"Dual drug loaded biodegradable Nanofibrous microsphere for improving anti-Colon Cancer activity","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10637-010-9499-y","article-title":"The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model","volume":"30","author":"Yu","year":"2012","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0560","doi-asserted-by":"crossref","DOI":"10.3390\/nano11071697","article-title":"Doxorubicin Embedded into Nanofibrillated Bacterial Cellulose (NFBC) Produces a Promising Therapeutic Outcome for Peritoneally Metastatic Gastric Cancer in Mice Models via Intraperitoneal Direct Injection","volume":"11","author":"Ando","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0565","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1349-7006.2012.02274.x","article-title":"Antitumor effect and pharmacokinetics of intraperitoneal NK105, a nanomicellar paclitaxel formulation for peritoneal dissemination","volume":"103","author":"Emoto","year":"2012","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0570","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10585-022-10173-8","article-title":"Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review","volume":"39","author":"Wintjens","year":"2022","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0575","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jconrel.2021.12.004","article-title":"I.P.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors","volume":"341","author":"Ando-Matsuoka","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0580","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/ijp.ijp_860_22","article-title":"Translational research: bridging the gap between preclinical and clinical research","volume":"54","author":"Mahalmani","year":"2022","journal-title":"Indian J. Pharm."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0585","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0590","first-page":"9286","article-title":"Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer","volume":"20","author":"Sugarbaker","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13050963","article-title":"Mouse models of peritoneal carcinomatosis to develop clinical applications","volume":"13","author":"Bella","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0600","series-title":"Thermogel Formulation for Combination Drug Delivery, US 10682415 B2","author":"Kwon","year":"2013"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0605","series-title":"Compositions and Methods for Treating Ovarian Cancer Including Preventing the Recurrence Thereof, WO 2015\/048354 A1","author":"Markland","year":"2013"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0610","series-title":"Implantable Depots for Localized, Sustained, Controlled Release of therapeutic Agents to Treat Cancer and Related Conditions, WO 2022\/082196 A1","author":"Steven","year":"2020"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0615","series-title":"Medicament, Method, and Drug Delivery Device for Treatment of Ovarian Cancer, WO 2013\/170069 A1","author":"Cima","year":"2012"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0620","series-title":"Pharmaceutical Composition, US 9220773 B2","author":"Chirwa","year":"2010"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0625","series-title":"Intraoperative Topically-Applied Non-Implantable Rapid Release Patch, US 10478403 B1","author":"Golberg","year":"2017"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0630","series-title":"Gold Nanoparticle-Containing Hydrogel Films and Chemotherapeutic Methods for Using Same, WO 2020\/167868 A1","author":"Ziemys","year":"2019"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0635","series-title":"Tumor-Targeting Drug-Loaded Particles, WO 2004\/089291 A2","author":"Au","year":"2003"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0640","series-title":"Hyperbranched Polyglycerol-Coated Particles and Methods of Making and Using Thereof, US 10238581 B2","author":"Deng","year":"2014"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0645","series-title":"PACA and Cabazitaxel for Anti-Cancer Treatment, US 11806330 B2","author":"Morch","year":"2018"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0650","series-title":"Drug Delivery System for Treatment of Cancer, US 2022\/0257525 A1","author":"Morch","year":"2019"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0655","series-title":"Block Copolymer for Intraperitoneal Administration Containing Anti-Cancer Agent, Micelle Preparation, and Cancer Therapeutic Agent Comprising the Micelle Preparation as Active Ingredient, WO 2011\/049042 A1","author":"Akatsu","year":"2009"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0660","series-title":"Liposomal Enhanced Intra-Peritoneal Chemotherapy, US 2022\/0000777 A1","author":"Oefelein","year":"2018"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0665","series-title":"Delayed Delivery of aNticancer Drugs, EP 3701943 A1","author":"Sahoo","year":"2019"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0670","series-title":"Formulations Containing Mucin-Affecting Proteases, US 2021\/0008180 A1","author":"Morris","year":"2018"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0675","series-title":"Intraperitoneally-Administered Nanocarriers that Release Their Therapeutic Load Based on the Inflammatory Environment of Cancers, US 9532949 B2","author":"Zeineldin","year":"2011"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0680","series-title":"Use of Paclitaxel Particles, WO 2015\/187194 A1","author":"Williamson","year":"2014"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0685","series-title":"Taxane Particles and Their Use, US 9814685 B2","author":"Baltezor","year":"2015"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0690","series-title":"Methods for Solid Tumor Treatment, US 10391090 B2","author":"Baltezor","year":"2016"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0695","series-title":"Local Delivery of Antineoplastic Particles in Combination with Systemic Delivery of Immunotherapeutic Agents for the Treatment of Cancer, US 11058639 B2","author":"Dizerega","year":"2017"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0700","series-title":"Sustained Release Hydrophobic Bioactive PLGA Microspheres, US 6447796 B1","author":"Vook","year":"1994"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0705","series-title":"Methods for Treating Ovarian Cancer, Poly (Phosphoester) Compositions, and Biodegradable Articles for Same, US 6350464 B1","author":"Dang","year":"1999"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0710","series-title":"Methods and Compositions for Enhancing Delivery of Therapeutic Agents to Tissues, US 7217735 B1","author":"Au","year":"1999"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0715","series-title":"Compositions for Treatment of Malignant Effusions, and Methods of Making and Using the Same, US 2002\/0141966 A1","author":"Dang","year":"2000"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0720","series-title":"Tumor Targeting Drug-Loaded Particles, US 2006\/0034925 A1","author":"Au","year":"2004"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0725","series-title":"Polymer-Based Compositions and Methods for Treatment of Peritoneal Disorders, WO 2011\/084458 A2","author":"Fu","year":"2009"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0730","series-title":"Holthuis Josephus Johannes Maria, Controlled Release System, US 2014\/0199244 A1","author":"Rijcken","year":"2011"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0735","series-title":"Compositions and Methods of Tumor Treatment Utilizing Nanoparticles, US 2018\/0028444 A1","author":"Chuang","year":"2015"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0740","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jconrel.2013.09.026","article-title":"Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice","volume":"172","author":"Stirland","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0745","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/pp-2017-0010","article-title":"Pharmacological principles of intraperitoneal and bidirectional chemotherapy","volume":"2","author":"de Bree","year":"2017","journal-title":"Pleura Peritoneum"},{"key":"10.1016\/j.jconrel.2024.07.017_bb0750","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2006.02.029","article-title":"A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a gynecologic oncology group study","volume":"103","author":"Armstrong","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jconrel.2024.07.017_bb0755","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2022.423","article-title":"Improving quality and efficiency of translational research: environmental scan of adaptive capacity and preparedness of clinical and translational science award program hubs","volume":"7","author":"Shah","year":"2023","journal-title":"J. Clin. Transl. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T20:54:36Z","timestamp":1725742476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924004486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":151,"alternative-id":["S0168365924004486"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.017","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}